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Peritonitis · Sepsis · Liver
Infecções bacterianas em doentes com cirrose 
admitidos no hospital
Palavras Chave
Peritonite · Sépsis · Fígado
Bacterial infections are frequently diagnosed in ad-
vanced cirrhosis and are associated with the development 
of organ failure (acute-on-chronic liver failure) and worse 
survival [1, 2]. 
In their work, published in this issue, Gomes et al. [3] 
retrospectively studied the prevalence of bacterial infec-
tions in a single-center large sample of patients with cir-
rhosis and bacterial infections admitted to a medical ward 
from 2008 to 2014 (372 out of 964 admissions in noncon-
tinuous years). Their main findings were the following: 
(1) overall, the most frequent infections diagnosed were 
urinary tract infection (n = 121; 32.5%), respiratory tract 
infection (n = 109; 29.3%), and spontaneous bacterial 
peritonitis (n = 97; 26.1%); (2) overall, bacteria were iden-
tified in 198 (53.2%) cases, with 124 (62.6%) of those be-
ing Gram negative; (3) from 2008 to 2014, while the prev-
alence of community-acquired infections increased (49.0 
vs. 70.7%), the prevalence of nosocomial infections de-
creased (51.0 vs. 29.3%); (4) from 2008 to 2014, the 
prevalence of multiresistant bacteria increased (9.6 vs. 
14.4%) – overall, 77.8% (42/54) of those cases were noso-
comial; (5) from 2008 to 2014, while the median MELD 
score decreased (17 vs. 14), the in-hospital mortality rate 
increased (7.0 vs. 25.0%).
The findings of Gomes et al. [3] provide a real-life 
characterization of the current epidemiology of bacterial 
infections in patients with cirrhosis admitted to a large 
district hospital in the north of Portugal. Furthermore, 
they emphasize some key characteristics of bacterial in-
fections in this group of patients [4]: they are frequent 
(38.6% of ward stays), but a positive microbiological di-
agnosis is often lacking (46.8%); therefore, a great deal of 
clinical suspicion is needed to make the working diagno-
sis; in a cohort of patients admitted to the ward largely 
from the emergency department (89.5%), Gram-negative 
and nonresistant bacteria are still preponderant; thus, 
current protocols of antimicrobial treatments may still 
apply effectively.
Despite all of this, the findings of Gomes et al. [3] raise 
several questions. The first one is: why is nosocomial in-
fection rate decreasing over time? As some relevant fac-
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tors to this discussion were not provided (e.g., history of 
antibiotic exposure or invasive procedures), it is not easy 
to find answers in this report. Therefore, may there be any 
specific hospital-led program ongoing dedicated to miti-
gating the risk of in-hospital acquired infection? If so, this 
may point out the real benefit of investing time and re-
sources in such type of programs [5]. 
Another question is: why is hospital mortality on the 
rise? Despite their efforts, Gomes et al. [3] did not provide 
a robust answer to this question either. Therefore, we can 
only speculate about the real justification for this fact. Is 
it related to patients’ comorbidities, complications of in-
fection and access to higher levels of care, complications 
of portal hypertension, or even access to timely assess-
ment for liver transplantation?
As important questions obviously remain unanswered, 
we can only hope that future studies with the collabora-
tion of several national centers treating patients with cir-
rhosis, and with the help of specific medical societies, will 
shed some light on those ambiguous topics.  
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